The Neuroprotective Role of MiR‐124‐3p in a 6‐Hydroxydopamine‐Induced Cell Model of Parkinson's Disease via the Regulation of ANAX5
ABSTRACT Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by a progressive loss of dopaminergic neurons in the midbrain. Several pathogenetic factors have been involved in the onset and progression of PD, including inflammation, oxidative stress, unf...
Saved in:
Published in | Journal of cellular biochemistry Vol. 119; no. 1; pp. 269 - 277 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ABSTRACT
Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by a progressive loss of dopaminergic neurons in the midbrain. Several pathogenetic factors have been involved in the onset and progression of PD, including inflammation, oxidative stress, unfolded protein accumulation, and apoptosis. Ample evidence indicates that miRNAs could regulate post‐transcriptional gene expression and neuronal disease. In this study, we evaluated the effects and mechanism of miR‐124‐3p on 6‐hydroxydopamine (6‐OHDA)‐induced neurotoxicity in PC12 cells and SH‐SY5Y cells. qRT‐PCR results showed that the level of miR‐124‐3p was downregulated in 6‐OHDA‐treated PC12 and SH‐SY5Y cells, and overexpression of miR‐124‐3p significantly promoted the cell viability of 6‐OHDA‐treated PC12 and SH‐SY5Y cells, whereas miR‐124‐3p inhibitor reversed these effects. In addition, PC12 or SH‐SY5Y cells were treated with miR‐124‐3p mimics or inhibitors following 6‐OHDA administration, which mediated cell apoptosis and downregulation or upregulation of Caspase‐3 activity, respectively. A luciferase reporter assay revealed that annexinA5 (ANXA5) is a direct target gene of miR‐124‐3p, and miR‐124‐3p overexpression markedly downregulated the level of ANXA5. Strikingly, further analysis showed that miR‐124‐3p enhanced the viability of 6‐OHDA‐treated PC12 or SH‐SY5Y cells by targeting ANXA5, which was associated with the stimulation of the ERK pathway. This study revealed that miR‐124‐3p may play a neuroprotective role in PD; this observation may provide new ideas and therapeutic targets for PD. J. Cell. Biochem. 119: 269–277, 2018. © 2017 Wiley Periodicals, Inc.
This study revealed that miR‐124‐3p may play a neuroprotective role in PD; this observation may provide new ideas and therapeutic targets for PD. |
---|---|
AbstractList | Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by a progressive loss of dopaminergic neurons in the midbrain. Several pathogenetic factors have been involved in the onset and progression of PD, including inflammation, oxidative stress, unfolded protein accumulation, and apoptosis. Ample evidence indicates that miRNAs could regulate post-transcriptional gene expression and neuronal disease. In this study, we evaluated the effects and mechanism of miR-124-3p on 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in PC12 cells and SH-SY5Y cells. qRT-PCR results showed that the level of miR-124-3p was downregulated in 6-OHDA-treated PC12 and SH-SY5Y cells, and overexpression of miR-124-3p significantly promoted the cell viability of 6-OHDA-treated PC12 and SH-SY5Y cells, whereas miR-124-3p inhibitor reversed these effects. In addition, PC12 or SH-SY5Y cells were treated with miR-124-3p mimics or inhibitors following 6-OHDA administration, which mediated cell apoptosis and downregulation or upregulation of Caspase-3 activity, respectively. A luciferase reporter assay revealed that annexinA5 (ANXA5) is a direct target gene of miR-124-3p, and miR-124-3p overexpression markedly downregulated the level of ANXA5. Strikingly, further analysis showed that miR-124-3p enhanced the viability of 6-OHDA-treated PC12 or SH-SY5Y cells by targeting ANXA5, which was associated with the stimulation of the ERK pathway. This study revealed that miR-124-3p may play a neuroprotective role in PD; this observation may provide new ideas and therapeutic targets for PD. J. Cell. Biochem. 119: 269-277, 2018. © 2017 Wiley Periodicals, Inc. Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by a progressive loss of dopaminergic neurons in the midbrain. Several pathogenetic factors have been involved in the onset and progression of PD, including inflammation, oxidative stress, unfolded protein accumulation, and apoptosis. Ample evidence indicates that miRNAs could regulate post-transcriptional gene expression and neuronal disease. In this study, we evaluated the effects and mechanism of miR-124-3p on 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in PC12 cells and SH-SY5Y cells. qRT-PCR results showed that the level of miR-124-3p was downregulated in 6-OHDA-treated PC12 and SH-SY5Y cells, and overexpression of miR-124-3p significantly promoted the cell viability of 6-OHDA-treated PC12 and SH-SY5Y cells, whereas miR-124-3p inhibitor reversed these effects. In addition, PC12 or SH-SY5Y cells were treated with miR-124-3p mimics or inhibitors following 6-OHDA administration, which mediated cell apoptosis and downregulation or upregulation of Caspase-3 activity, respectively. A luciferase reporter assay revealed that annexinA5 (ANXA5) is a direct target gene of miR-124-3p, and miR-124-3p overexpression markedly downregulated the level of ANXA5. Strikingly, further analysis showed that miR-124-3p enhanced the viability of 6-OHDA-treated PC12 or SH-SY5Y cells by targeting ANXA5, which was associated with the stimulation of the ERK pathway. This study revealed that miR-124-3p may play a neuroprotective role in PD; this observation may provide new ideas and therapeutic targets for PD. J. Cell. Biochem. 119: 269-277, 2018. © 2017 Wiley Periodicals, Inc.Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by a progressive loss of dopaminergic neurons in the midbrain. Several pathogenetic factors have been involved in the onset and progression of PD, including inflammation, oxidative stress, unfolded protein accumulation, and apoptosis. Ample evidence indicates that miRNAs could regulate post-transcriptional gene expression and neuronal disease. In this study, we evaluated the effects and mechanism of miR-124-3p on 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in PC12 cells and SH-SY5Y cells. qRT-PCR results showed that the level of miR-124-3p was downregulated in 6-OHDA-treated PC12 and SH-SY5Y cells, and overexpression of miR-124-3p significantly promoted the cell viability of 6-OHDA-treated PC12 and SH-SY5Y cells, whereas miR-124-3p inhibitor reversed these effects. In addition, PC12 or SH-SY5Y cells were treated with miR-124-3p mimics or inhibitors following 6-OHDA administration, which mediated cell apoptosis and downregulation or upregulation of Caspase-3 activity, respectively. A luciferase reporter assay revealed that annexinA5 (ANXA5) is a direct target gene of miR-124-3p, and miR-124-3p overexpression markedly downregulated the level of ANXA5. Strikingly, further analysis showed that miR-124-3p enhanced the viability of 6-OHDA-treated PC12 or SH-SY5Y cells by targeting ANXA5, which was associated with the stimulation of the ERK pathway. This study revealed that miR-124-3p may play a neuroprotective role in PD; this observation may provide new ideas and therapeutic targets for PD. J. Cell. Biochem. 119: 269-277, 2018. © 2017 Wiley Periodicals, Inc. ABSTRACT Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by a progressive loss of dopaminergic neurons in the midbrain. Several pathogenetic factors have been involved in the onset and progression of PD, including inflammation, oxidative stress, unfolded protein accumulation, and apoptosis. Ample evidence indicates that miRNAs could regulate post‐transcriptional gene expression and neuronal disease. In this study, we evaluated the effects and mechanism of miR‐124‐3p on 6‐hydroxydopamine (6‐OHDA)‐induced neurotoxicity in PC12 cells and SH‐SY5Y cells. qRT‐PCR results showed that the level of miR‐124‐3p was downregulated in 6‐OHDA‐treated PC12 and SH‐SY5Y cells, and overexpression of miR‐124‐3p significantly promoted the cell viability of 6‐OHDA‐treated PC12 and SH‐SY5Y cells, whereas miR‐124‐3p inhibitor reversed these effects. In addition, PC12 or SH‐SY5Y cells were treated with miR‐124‐3p mimics or inhibitors following 6‐OHDA administration, which mediated cell apoptosis and downregulation or upregulation of Caspase‐3 activity, respectively. A luciferase reporter assay revealed that annexinA5 (ANXA5) is a direct target gene of miR‐124‐3p, and miR‐124‐3p overexpression markedly downregulated the level of ANXA5. Strikingly, further analysis showed that miR‐124‐3p enhanced the viability of 6‐OHDA‐treated PC12 or SH‐SY5Y cells by targeting ANXA5, which was associated with the stimulation of the ERK pathway. This study revealed that miR‐124‐3p may play a neuroprotective role in PD; this observation may provide new ideas and therapeutic targets for PD. J. Cell. Biochem. 119: 269–277, 2018. © 2017 Wiley Periodicals, Inc. This study revealed that miR‐124‐3p may play a neuroprotective role in PD; this observation may provide new ideas and therapeutic targets for PD. |
Author | Tai, Li‐Wen Liu, Ning‐Ning Shi, Fang‐Kun Zhang, Bing Dong, Rui‐Fang Liu, Hong‐Mei |
Author_xml | – sequence: 1 givenname: Rui‐Fang orcidid: 0000-0002-8861-559X surname: Dong fullname: Dong, Rui‐Fang email: dongrf061@163.com organization: Cangzhou Central Hospital – sequence: 2 givenname: Bing surname: Zhang fullname: Zhang, Bing organization: The First Hospital of Shijiazhuang – sequence: 3 givenname: Li‐Wen surname: Tai fullname: Tai, Li‐Wen organization: The Second Hospital of Hebei Medical University – sequence: 4 givenname: Hong‐Mei surname: Liu fullname: Liu, Hong‐Mei organization: Cangzhou Central Hospital – sequence: 5 givenname: Fang‐Kun surname: Shi fullname: Shi, Fang‐Kun organization: Cangzhou Central Hospital – sequence: 6 givenname: Ning‐Ning surname: Liu fullname: Liu, Ning‐Ning organization: Cangzhou Central Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28543594$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1OGzEUhS1EBYGy6AtUlrpoWQT8PzPLNC2Fij9FIHU3csbXrdOJndoztNl1z4Zn7JPUIZQFUtnYlvWde--5Zwdt-uABoVeUHFBC2OGsmR4wRQuygQaUVMVQKCE20YAUnAwZp2wb7aQ0I4RUFWdbaJuVUnBZiQG6vfoG-Bz6GBYxdNB07gbwJLSAg8VnbvLn9x1lIp98gZ3HGqv8Pl6aGH4tTVjoufOQf0686RsweAxti8-CgXalv9Txu_Mp-LcJf3AJdAJ84zTucs8JfO1b3bngV-TofPRFvkQvrG4T7D3cu-j66OPV-Hh4evHpZDw6HTZcrgwxECUooAVIm-3qyk5VqSWnRQWWcEOgALBTzUtLqJVWiIZxYaQgsjLW8F30bl03W_7RQ-rquUtNnlx7CH2qaUU4VYqrIqNvnqCz0Eefp8uUUmWpSqoy9fqB6qdzMPUiurmOy_rfmjOwvwaaGFKKYB8RSupVhHWOsL6PMLOHT9jGdfeL6qJ27XOKn66F5f9L15_H79eKv-bVrlw |
CitedBy_id | crossref_primary_10_3389_fphar_2019_01555 crossref_primary_10_1016_j_bcp_2017_07_008 crossref_primary_10_18632_aging_202837 crossref_primary_10_1007_s11064_019_02825_1 crossref_primary_10_1159_000515661 crossref_primary_10_1007_s11481_019_09842_5 crossref_primary_10_3892_mmr_2019_10565 crossref_primary_10_3390_ijms21010120 crossref_primary_10_1007_s10811_018_1713_x crossref_primary_10_1016_j_lfs_2020_118019 crossref_primary_10_1111_jnc_15299 crossref_primary_10_1016_j_yexmp_2019_05_002 crossref_primary_10_1016_j_npep_2022_102283 crossref_primary_10_1002_iub_2171 crossref_primary_10_3390_jpm12050770 crossref_primary_10_1080_15384101_2020_1749447 crossref_primary_10_1186_s13046_020_01567_1 crossref_primary_10_1007_s10571_021_01091_6 crossref_primary_10_1016_j_phrs_2019_104515 crossref_primary_10_3390_ijms232315017 crossref_primary_10_1016_j_bbrc_2019_10_157 crossref_primary_10_3390_ijms21072418 crossref_primary_10_1016_j_ejphar_2021_174136 crossref_primary_10_1016_j_lfs_2021_119143 crossref_primary_10_3390_ijms21186513 crossref_primary_10_1007_s11033_021_06347_4 crossref_primary_10_3892_ijmm_2019_4080 crossref_primary_10_1002_jcp_30932 crossref_primary_10_1002_jcb_27861 crossref_primary_10_3390_ijms241813849 crossref_primary_10_1016_j_mcp_2019_101470 crossref_primary_10_3389_fcell_2020_00573 crossref_primary_10_1186_s13578_017_0194_y crossref_primary_10_1007_s12035_024_04111_w crossref_primary_10_3389_fncel_2021_771898 crossref_primary_10_1139_bcb_2019_0188 crossref_primary_10_1002_mds_27928 crossref_primary_10_1007_s11064_024_04130_y crossref_primary_10_1016_j_nantod_2021_101328 crossref_primary_10_3389_fnmol_2021_631553 crossref_primary_10_1007_s11064_019_02849_7 crossref_primary_10_1007_s00018_022_04398_9 crossref_primary_10_1016_j_arr_2020_101023 crossref_primary_10_1016_j_cbi_2019_108908 crossref_primary_10_1016_j_expneurol_2022_114154 crossref_primary_10_1007_s11011_023_01180_z crossref_primary_10_1002_jcla_23266 crossref_primary_10_3390_ijms21249582 crossref_primary_10_1186_s13075_020_2146_x crossref_primary_10_1016_j_neuro_2022_09_002 crossref_primary_10_15311_selcukdentj_800489 crossref_primary_10_1007_s12035_023_03849_z crossref_primary_10_1080_13102818_2020_1724829 crossref_primary_10_3390_cells12010075 crossref_primary_10_1016_j_ymthe_2022_06_003 crossref_primary_10_3389_fnins_2021_649982 crossref_primary_10_1177_17534259211068744 crossref_primary_10_1016_j_jksus_2020_04_012 crossref_primary_10_1166_jbt_2022_3116 |
Cites_doi | 10.1521/bumc.2017.81.1.53 10.1016/j.nucmedbio.2010.09.008 10.3233/CBM-160427 10.1016/j.bbamcr.2014.12.038 10.2174/1566524016666151123114608 10.1007/s11064-016-2148-x 10.5483/BMBRep.2002.35.1.024 10.2967/jnumed.107.045898 10.1080/23262133.2016.1256855 10.1007/s12035-016-0253-0 10.4062/biomolther.2013.026 10.1074/jbc.M004583200 10.1007/s10565-011-9209-3 10.3892/mmr.2016.5759 10.1016/j.toxlet.2011.11.032 10.1089/jmf.2016.3851 10.1186/1471-2407-8-294 10.1007/s12640-016-9699-0 10.1016/j.neuron.2007.11.018 10.3389/fnins.2016.00298 10.1016/S0301-0082(01)00003-X 10.18632/oncotarget.15149 10.1074/jbc.M113.450163 10.1038/cddis.2013.73 10.1159/000452521 10.1159/000430271 10.1007/s10072-017-2841-9 10.1186/s12885-016-2862-4 10.1111/j.1756-185X.2012.01759.x 10.1073/pnas.0906277106 10.4062/biomolther.2014.112 10.1126/science.1140481 10.1111/j.1471-4159.2010.07097.x 10.1038/sj.onc.1204062 10.1016/j.neulet.2013.02.069 10.1111/j.1742-4658.2009.07366.x 10.1016/j.compbiolchem.2014.10.005 10.1002/jnr.22427 10.1111/cas.12946 10.4062/biomolther.2016.223 |
ContentType | Journal Article |
Copyright | 2017 Wiley Periodicals, Inc. 2018 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2017 Wiley Periodicals, Inc. – notice: 2018 Wiley Periodicals, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7T7 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 |
DOI | 10.1002/jcb.26170 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE Virology and AIDS Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1097-4644 |
EndPage | 277 |
ExternalDocumentID | 28543594 10_1002_jcb_26170 JCB26170 |
Genre | article Journal Article |
GroupedDBID | --- -~X .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHQN AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABPVW ACAHQ ACBWZ ACCZN ACGFO ACGFS ACIWK ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AIAGR AIDQK AIDYY AITYG AIURR AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BLYAC BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IH2 IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LH6 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NDZJH NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RX1 RYL SAMSI SUPJJ SV3 UB1 V8K W8V W99 WBKPD WIB WIH WIK WJL WNSPC WOHZO WQJ WXSBR WYISQ XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE CITATION CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7T7 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 |
ID | FETCH-LOGICAL-c3530-22e48e6e17e5f109a9fb68a53179ef03d0e7eefba38f01f5f44c234d54059dfd3 |
IEDL.DBID | DR2 |
ISSN | 0730-2312 1097-4644 |
IngestDate | Fri Jul 11 10:03:12 EDT 2025 Fri Jul 25 12:11:55 EDT 2025 Thu Apr 03 07:08:14 EDT 2025 Thu Apr 24 23:11:24 EDT 2025 Tue Jul 01 05:02:42 EDT 2025 Wed Aug 20 07:26:19 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | 6-OHDA miR-124-3p PARKINSON'S DISEASE ANXA5 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3530-22e48e6e17e5f109a9fb68a53179ef03d0e7eefba38f01f5f44c234d54059dfd3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-8861-559X |
PMID | 28543594 |
PQID | 1966886816 |
PQPubID | 1006368 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1903166367 proquest_journals_1966886816 pubmed_primary_28543594 crossref_primary_10_1002_jcb_26170 crossref_citationtrail_10_1002_jcb_26170 wiley_primary_10_1002_jcb_26170_JCB26170 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2018 2018-01-00 20180101 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – month: 01 year: 2018 text: January 2018 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Journal of cellular biochemistry |
PublicationTitleAlternate | J Cell Biochem |
PublicationYear | 2018 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2011; 116 2015; 15 2017; 20 2017; 8 2015; 36 2013; 4 2017; 81 2013; 21 2017; 69 2017; 25 2016; 107 2002; 35 2017; S0888–S7543 2016; 10 2013; 543 2008; 57 2008; 8 2015; 1853 2016; 2016 2000; 275 2012; 15 2011; 38 2016; 16 2016; 14 2014; 22 2001; 20 2005; 46 2001; 65 2012; 209 2010; 88 2017; 31 2014; 53PB 2017; 30 2007; 317 2016; 3 2017; 38 2008; 49 2010; 277 2016; 42 2016; 40 2016 2017; 19 2012; 28 2014; 289 2009; 106 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_11_1 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_39_1 e_1_2_6_15_1 e_1_2_6_38_1 e_1_2_6_16_1 e_1_2_6_37_1 Boersma HH (e_1_2_6_7_1) 2005; 46 e_1_2_6_42_1 e_1_2_6_43_1 e_1_2_6_21_1 e_1_2_6_40_1 Matsumoto H (e_1_2_6_33_1) 2017; 69 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 Song Z (e_1_2_6_41_1) 2016; 2016 Mortezaei Z (e_1_2_6_34_1) 2017; 0888 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_44_1 e_1_2_6_28_1 e_1_2_6_45_1 e_1_2_6_27_1 e_1_2_6_46_1 Huang LH (e_1_2_6_20_1) 2017; 30 e_1_2_6_26_1 |
References_xml | – volume: 275 start-page: 39435 year: 2000 end-page: 39443 article-title: Requirement for erk activation in cisplatin‐induced apoptosis publication-title: J Biol Chem – volume: 69 start-page: 219 year: 2017 end-page: 225 article-title: Repetitive transcranial magnetic stimulation for Parkinson's disease: A review publication-title: Brain Nerve – volume: 31 start-page: 545 year: 2017 end-page: 559 article-title: Ra differentiation enhances dopaminergic features, changes redox parameters, and increases dopamine transporter dependency in 6‐hydroxydopamine‐induced neurotoxicity in sh‐sy5y cells publication-title: Neurotox Res – volume: 277 start-page: 2 year: 2010 end-page: 21 article-title: Erk and cell death: Mechanisms of erk‐induced cell death‐apoptosis, autophagy and senescence publication-title: FEBS J – volume: 2016 start-page: 1922 year: 2016 end-page: 1925 article-title: An implantable microelectrode array for dopamine and electrophysiological recordings in response to l‐dopa therapy for Parkinson's disease publication-title: Conf Proc IEEE Eng Med Biol Soc – volume: 543 start-page: 121 year: 2013 end-page: 125 article-title: Danshensu protects against 6‐hydroxydopamine‐induced damage of pc12 cells in vitro and dopaminergic neurons in zebrafish publication-title: Neurosci Lett – volume: 16 start-page: 826 year: 2016 article-title: Mir‐124‐3p functions as a tumor suppressor in breast cancer by targeting cbl publication-title: BMC Cancer – volume: 42 start-page: 1141 year: 2016 end-page: 1150 article-title: Tetramethylpyrazine analogue cxc195 protects against dopaminergic neuronal apoptosis via activation of pi3k/akt/gsk3beta signaling pathway in 6‐ohda‐induced Parkinson's disease mice publication-title: Neurochem Res – volume: 8 start-page: 24314 year: 2017 end-page: 24316 article-title: Mir‐124‐3p attenuates hyperphosphorylation of tau protein‐induced apoptosis via caveolin‐1‐pi3k/akt/gsk3beta pathway in n2a/app695swe cells publication-title: Oncotarget – volume: 81 start-page: 53 year: 2017 end-page: 105 article-title: A comprehensive overview of the neuropsychiatry of Parkinson's disease: A review publication-title: Bull Menninger Clin – volume: 88 start-page: 2682 year: 2010 end-page: 2692 article-title: Investigation of annexin a5 as a biomarker for Alzheimer's disease using neuronal cell culture and mouse model publication-title: J Neurosci Res – volume: S0888–S7543 start-page: 30010 year: 2017 end-page: 30011 article-title: Candidate novel long noncoding rnas, micrornas and putative drugs for Parkinson's disease using a robust and efficient genome‐wide association study publication-title: Genomics – volume: 3 start-page: e1256855 year: 2016 article-title: Traceable microrna‐124 loaded nanoparticles as a new promising therapeutic tool for Parkinson's disease publication-title: Neurogenesis (Austin) – volume: 38 start-page: 761 year: 2017 end-page: 767 article-title: Plasma levels of mir‐137 and mir‐124 are associated with Parkinson's disease but not with Parkinson's disease with depression publication-title: Neurol Sci – volume: 22 start-page: 519 year: 2014 end-page: 524 article-title: Role of annexin a5 on mitochondria‐dependent apoptosis induced by tetramethoxystilbene in human breast cancer cells publication-title: Biomol Ther (Seoul) – year: 2016 article-title: Micrornas in cerebrospinal fluid as potential biomarkers for Parkinson's disease and multiple system atrophy publication-title: Mol Neurobiol – volume: 35 start-page: 24 year: 2002 end-page: 27 article-title: Apoptotic signaling pathways: Caspases and stress‐activated protein kinases publication-title: J Biochem Mol Biol – volume: 30 start-page: 75 year: 2017 end-page: 78 article-title: Neodymium oxide induces cytotoxicity and activates nf‐kappab and caspase‐3 in nr8383 cells publication-title: Biomed Environ Sci – volume: 8 start-page: 294 year: 2008 article-title: Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis publication-title: BMC Cancer – volume: 49 start-page: 81S issue: Suppl 2 year: 2008 end-page: 95S article-title: In vivo detection of apoptosis publication-title: J Nucl Med – volume: 21 start-page: 190 year: 2013 end-page: 195 article-title: Annexin a5 as a new potential biomarker for cisplatin‐induced toxicity in human kidney epithelial cells publication-title: Biomol Ther (Seoul) – volume: 53PB start-page: 214 year: 2014 end-page: 225 article-title: Disruption of murine tcte3‐3 induces tissue specific apoptosis via co‐expression of anxa5 and pebp1 publication-title: Comput Biol Chem – volume: 14 start-page: 4015 year: 2016 end-page: 4022 article-title: Micrornas involved in Parkinson's disease: A systematic review publication-title: Mol Med Rep – volume: 106 start-page: 13052 year: 2009 end-page: 13057 article-title: Repression of alpha‐synuclein expression and toxicity by microrna‐7 publication-title: Proc Natl Acad Sci USA – volume: 36 start-page: 966 year: 2015 end-page: 979 article-title: Allicin protects pc12 cells against 6‐ohda‐induced oxidative stress and mitochondrial dysfunction via regulating mitochondrial dynamics publication-title: Cell Physiol Biochem – volume: 65 start-page: 135 year: 2001 end-page: 172 article-title: Molecular pathways involved in the neurotoxicity of 6‐ohda, dopamine and mptp: Contribution to the apoptotic theory in Parkinson's disease publication-title: Prog Neurobiol – volume: 15 start-page: 980 year: 2015 end-page: 989 article-title: The role of mir‐124 in Alzheimer's disease model by targeting delta in notch signaling pathway publication-title: Curr Mol Med – volume: 116 start-page: 240 year: 2011 end-page: 247 article-title: In vivo regulation of amyloid precursor protein neuronal splicing by micrornas publication-title: J Neurochem – volume: 25 start-page: 177 year: 2017 end-page: 185 article-title: Auranofin suppresses plasminogen activator inhibitor‐2 expression through annexin a5 induction in human prostate cancer cells publication-title: Biomol Ther (Seoul) – volume: 15 start-page: e124 year: 2012 end-page: e126 article-title: Anti‐annexin v antibodies in neuro‐behcet patients: Clinical significance and relation to disease activity publication-title: Int J Rheum Dis – volume: 20 start-page: 116 year: 2017 end-page: 123 article-title: Humulus japonicus prevents dopaminergic neuron death in 6‐hydroxydopamine‐induced models of Parkinson's disease publication-title: J Med Food – volume: 107 start-page: 899 year: 2016 end-page: 907 article-title: Microrna‐124‐3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting pim1 in astrocytoma publication-title: Cancer Sci – volume: 4 start-page: e545 year: 2013 article-title: Influence of microrna deregulation on chaperone‐mediated autophagy and alpha‐synuclein pathology in Parkinson's disease publication-title: Cell Death Dis – volume: 57 start-page: 41 year: 2008 end-page: 55 article-title: Members of the mirna‐200 family regulate olfactory neurogenesis publication-title: Neuron – volume: 28 start-page: 89 year: 2012 end-page: 101 article-title: Toxicity of 6‐hydroxydopamine: Live cell imaging of cytoplasmic redox flux publication-title: Cell Biol Toxicol – volume: 46 start-page: 2035 year: 2005 end-page: 2050 article-title: Past, present, and future of annexin a5: From protein discovery to clinical applications publication-title: J Nucl Med – volume: 19 start-page: 93 year: 2017 end-page: 101 article-title: Microrna‐124‐3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting aurka publication-title: Cancer Biomark – volume: 20 start-page: 147 year: 2001 end-page: 155 article-title: Taxol‐induced apoptosis depends on map kinase pathways (erk and p38) and is independent of p53 publication-title: Oncogene – volume: 209 start-page: 94 year: 2012 end-page: 105 article-title: The mir‐124 regulates the expression of bace1/beta‐secretase correlated with cell death in Alzheimer's disease publication-title: Toxicol Lett – volume: 317 start-page: 1220 year: 2007 end-page: 1224 article-title: A microrna feedback circuit in midbrain dopamine neurons publication-title: Science – volume: 289 start-page: 2469 year: 2014 end-page: 2481 article-title: Role of annexin a5 in cisplatin‐induced toxicity in renal cells: Molecular mechanism of apoptosis publication-title: J Biol Chem – volume: 1853 start-page: 2033 year: 2015 end-page: 2044 article-title: Annexin‐a5 promotes membrane resealing in human trophoblasts publication-title: Biochim Biophys Acta – volume: 10 start-page: 298 year: 2016 article-title: Micrornas: Emerging targets regulating oxidative stress in the models of Parkinson's disease publication-title: Front Neurosci – volume: 38 start-page: 381 year: 2011 end-page: 392 article-title: Site‐specific 68ga‐labeled annexin a5 as a pet imaging agent for apoptosis publication-title: Nucl Med Biol – volume: 40 start-page: 18 year: 2016 end-page: 26 article-title: Involvement of microrna‐135a‐5p in the protective effects of hydrogen sulfide against Parkinson's disease publication-title: Cell Physiol Biochem – ident: e_1_2_6_24_1 doi: 10.1521/bumc.2017.81.1.53 – ident: e_1_2_6_4_1 doi: 10.1016/j.nucmedbio.2010.09.008 – ident: e_1_2_6_46_1 doi: 10.3233/CBM-160427 – ident: e_1_2_6_9_1 doi: 10.1016/j.bbamcr.2014.12.038 – ident: e_1_2_6_26_1 doi: 10.2174/1566524016666151123114608 – ident: e_1_2_6_10_1 doi: 10.1007/s11064-016-2148-x – ident: e_1_2_6_11_1 doi: 10.5483/BMBRep.2002.35.1.024 – ident: e_1_2_6_5_1 doi: 10.2967/jnumed.107.045898 – ident: e_1_2_6_37_1 doi: 10.1080/23262133.2016.1256855 – ident: e_1_2_6_32_1 doi: 10.1007/s12035-016-0253-0 – ident: e_1_2_6_27_1 doi: 10.4062/biomolther.2013.026 – ident: e_1_2_6_42_1 doi: 10.1074/jbc.M004583200 – volume: 46 start-page: 2035 year: 2005 ident: e_1_2_6_7_1 article-title: Past, present, and future of annexin a5: From protein discovery to clinical applications publication-title: J Nucl Med – ident: e_1_2_6_16_1 doi: 10.1007/s10565-011-9209-3 – ident: e_1_2_6_14_1 doi: 10.3892/mmr.2016.5759 – ident: e_1_2_6_17_1 doi: 10.1016/j.toxlet.2011.11.032 – ident: e_1_2_6_36_1 doi: 10.1089/jmf.2016.3851 – volume: 0888 start-page: 30010 year: 2017 ident: e_1_2_6_34_1 article-title: Candidate novel long noncoding rnas, micrornas and putative drugs for Parkinson's disease using a robust and efficient genome‐wide association study publication-title: Genomics – ident: e_1_2_6_38_1 doi: 10.1186/1471-2407-8-294 – ident: e_1_2_6_31_1 doi: 10.1007/s12640-016-9699-0 – ident: e_1_2_6_12_1 doi: 10.1016/j.neuron.2007.11.018 – ident: e_1_2_6_44_1 doi: 10.3389/fnins.2016.00298 – ident: e_1_2_6_6_1 doi: 10.1016/S0301-0082(01)00003-X – ident: e_1_2_6_23_1 doi: 10.18632/oncotarget.15149 – ident: e_1_2_6_21_1 doi: 10.1074/jbc.M113.450163 – ident: e_1_2_6_2_1 doi: 10.1038/cddis.2013.73 – volume: 69 start-page: 219 year: 2017 ident: e_1_2_6_33_1 article-title: Repetitive transcranial magnetic stimulation for Parkinson's disease: A review publication-title: Brain Nerve – ident: e_1_2_6_30_1 doi: 10.1159/000452521 – ident: e_1_2_6_29_1 doi: 10.1159/000430271 – ident: e_1_2_6_28_1 doi: 10.1007/s10072-017-2841-9 – volume: 2016 start-page: 1922 year: 2016 ident: e_1_2_6_41_1 article-title: An implantable microelectrode array for dopamine and electrophysiological recordings in response to l‐dopa therapy for Parkinson's disease publication-title: Conf Proc IEEE Eng Med Biol Soc – ident: e_1_2_6_43_1 doi: 10.1186/s12885-016-2862-4 – ident: e_1_2_6_18_1 doi: 10.1111/j.1756-185X.2012.01759.x – ident: e_1_2_6_22_1 doi: 10.1073/pnas.0906277106 – ident: e_1_2_6_19_1 doi: 10.4062/biomolther.2014.112 – ident: e_1_2_6_25_1 doi: 10.1126/science.1140481 – ident: e_1_2_6_40_1 doi: 10.1111/j.1471-4159.2010.07097.x – ident: e_1_2_6_3_1 doi: 10.1038/sj.onc.1204062 – ident: e_1_2_6_13_1 doi: 10.1016/j.neulet.2013.02.069 – ident: e_1_2_6_8_1 doi: 10.1111/j.1742-4658.2009.07366.x – volume: 30 start-page: 75 year: 2017 ident: e_1_2_6_20_1 article-title: Neodymium oxide induces cytotoxicity and activates nf‐kappab and caspase‐3 in nr8383 cells publication-title: Biomed Environ Sci – ident: e_1_2_6_35_1 doi: 10.1016/j.compbiolchem.2014.10.005 – ident: e_1_2_6_45_1 doi: 10.1002/jnr.22427 – ident: e_1_2_6_15_1 doi: 10.1111/cas.12946 – ident: e_1_2_6_39_1 doi: 10.4062/biomolther.2016.223 |
SSID | ssj0009932 |
Score | 2.4824266 |
Snippet | ABSTRACT
Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by a progressive loss of dopaminergic neurons in the... Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by a progressive loss of dopaminergic neurons in the midbrain.... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 269 |
SubjectTerms | 6-Hydroxydopamine 6‐OHDA Animals Annexin A5 - biosynthesis Annexin A5 - genetics ANXA5 Apoptosis Caspase Caspase-3 Chromosome 3 Dopamine receptors Gene expression Gene Expression Regulation - drug effects Mesencephalon Metabolic pathways MicroRNAs - biosynthesis MicroRNAs - genetics miR‐124‐3p Models, Biological Movement disorders Neurodegenerative diseases Neuroprotection Neurotoxicity Oxidative stress Oxidopamine - adverse effects Oxidopamine - pharmacology Parkinson Disease, Secondary - chemically induced Parkinson Disease, Secondary - genetics Parkinson Disease, Secondary - metabolism Parkinson Disease, Secondary - pathology PARKINSON'S DISEASE PC12 Cells Pheochromocytoma cells Post-transcription Protein folding Rats |
Title | The Neuroprotective Role of MiR‐124‐3p in a 6‐Hydroxydopamine‐Induced Cell Model of Parkinson's Disease via the Regulation of ANAX5 |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcb.26170 https://www.ncbi.nlm.nih.gov/pubmed/28543594 https://www.proquest.com/docview/1966886816 https://www.proquest.com/docview/1903166367 |
Volume | 119 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqShVcKJTXQkEGIcEl28SxnVicloVqVak9rKi0B6QojsfVQshW3V2k9tR7L_xGfgljO0lVHhLiEjnJRHbsmfHn1zeEvFJag86EirjJZMQtDndKmySRBoXoVTEWGzehf3gkJ8f8YCZmG-RtdxYm8EP0E27OMry_dgZe6uXeNWno50oPPZ04-l-3V8sBouk1dRT2u34FATU4QgzDOlahmO31X97si34DmDfxqu9w9rfJp66oYZ_Jl-F6pYfVxS8sjv_5L3fJnRaI0lHQnHtkA5odshVCU57vkFvjLhLcfXKFukQ9i0fL6oAekk4XNdCFpYfz6Y_L79h_4zU9pfOGllRienJuXMkNDsq_YvnwiYsSUoGhY6hr6mKw1e57d-zan0B7vaTvw2oR_TYvKQJTOoWTNrqYkxwdjWbiATne__BxPInaIA5RlQpX9wx4DhKSDIRNYlUqq2VeoulnCmycmhgyAKvLNLdxYoXlvGIpNw5JKmNN-pBsNosGHhOKtywTCNi4jLlRUhubVBloYazlecwG5E3XnEXVMpy7QBt1EbiZWYH1XPh6HpCXvehpoPX4k9BupxNFa9nLAj2WzHOZJ3JAXvSvsUHcQkvZwGLtZNBVIpST2YA8CrrU5-JOrKZCcSys14i_Z18cjN_5xJN_F31KbiOiy8Mc0S7ZXJ2t4RmippV-7s3jJ3NDFAc |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlQuPAqlCwUMQoJLtnk4TixxWbZUS-nuYdVKe0FRHI_R0pCt6C5SOXHnwm_klzB2HlV5SIhL5CRj2bFnPJ_t-BuAZ1IpVEksPa4T4XFD053cBIGnUBJ6lWHoa7ugP56I0TE_mMWzNXjZnoWp-SG6BTdrGW68tgZuF6R3L1hDPxSq7_jEr8BVG9HbMufvTS_Io8jzuj0E0mGPUEzY8gr54W6X9bI3-g1iXkaszuXs34R3bWXrP01O-qul6hdffuFx_N-vuQU3GizKBrXy3IY1rDbhWh2d8nwTNoZtMLg78I3UiTkij4bYgQZJNl2UyBaGjefTH1-_kwuna3TK5hXLmaD06Fzbqmual3-kCtITGyikQM2GWJbMhmErbX578todQnt-xvbqDSP2eZ4zwqZsiu-bAGNWcjAZzOK7cLz_-mg48po4Dl4RxbbxQ-QpCgwSjE3gy1waJdKcrD-RaPxI-5ggGpVHqfEDExvOizDi2oJJqY2OtmC9WlS4DYxuwyQmzMaFz7UUSpugSFDF2hie-mEPXrT9mRUNybmNtVFmNT1zmFE7Z66de_C0Ez2tmT3-JLTTKkXWGPdZRoOWSFORBqIHT7rX1CF2ryWvcLGyMjRaEpoTSQ_u1crUlWIPrUax5FRZpxJ_Lz47GL5yifv_LvoYNkZH48Ps8M3k7QO4TgAvrZeMdmB9-WmFDwlELdUjZys_AZ4xGCM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4ti3hceCyvwgIGIcEl3TwcJxan0lKVha1QxUo9IEVxPEaFkFZsi7ScuHPhN_JLGDuP1fKQEJfIScayY894PtvxNwCPpFKoklh6XCfC44amO7kJAk-hJPQqw9DXdkH_YComh3x_Hs-34Gl7Fqbmh-gW3KxluPHaGvhKm70T0tD3heo7OvEzcJYLX9q4DaPZCXcUOV63hUAq7BGICVtaIT_c67Kedka_IczTgNV5nPFleNvWtf7R5EN_s1b94ssvNI7_-TFX4FKDRNmgVp2rsIXVDpyrY1Me78CFYRsK7hp8I2VijsajoXWgIZLNliWypWEHi9mPr9_JgdM1WrFFxXImKD051rbmmmblH6l-9MSGCSlQsyGWJbNB2Eqb3567dkfQHh-xUb1dxD4vckbIlM3wXRNezEoOpoN5fB0Ox8_fDCdeE8XBK6LYtn2IPEWBQYKxCXyZS6NEmpPtJxKNH2kfE0Sj8ig1fmBiw3kRRlxbKCm10dEN2K6WFd4CRrdhEhNio_7mWgqlTVAkqGJtDE_9sAdP2u7Miobi3EbaKLOanDnMqJ0z1849eNiJrmpejz8J7bY6kTWmfZTRkCXSVKSB6MGD7jV1iN1pyStcbqwMjZWE5UTSg5u1LnWl2COrUSw5VdZpxN-Lz_aHz1zi9r-L3ofzr0fj7NWL6cs7cJHQXVqvF-3C9vrTBu8Sglqre85SfgJKfBbS |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Neuroprotective+Role+of+MiR%E2%80%90124%E2%80%903p+in+a+6%E2%80%90Hydroxydopamine%E2%80%90Induced+Cell+Model+of+Parkinson%27s+Disease+via+the+Regulation+of+ANAX5&rft.jtitle=Journal+of+cellular+biochemistry&rft.au=Dong%2C+Rui%E2%80%90Fang&rft.au=Zhang%2C+Bing&rft.au=Tai%2C+Li%E2%80%90Wen&rft.au=Liu%2C+Hong%E2%80%90Mei&rft.date=2018-01-01&rft.issn=0730-2312&rft.eissn=1097-4644&rft.volume=119&rft.issue=1&rft.spage=269&rft.epage=277&rft_id=info:doi/10.1002%2Fjcb.26170&rft.externalDBID=10.1002%252Fjcb.26170&rft.externalDocID=JCB26170 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0730-2312&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0730-2312&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0730-2312&client=summon |